Role of p53 family members p73 and p63 in human hematological malignancies
Authors:
- 21 May 2012
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 53 (11) , 2116-2129
Abstract
P53, mutated in over half of human cancers and about 13% of all hematological malignancies, maintains genomic integrity and triggers cellular senescence and apoptosis of damaged cells. In contrast to p53, the homologs p73 and p63 play critical roles in development of the central nervous system and skin/limbs, respectively. Moreover, dependent on the context they can exert tumor suppressor activities that cooperate with p53. Unlike p53, p73 and p63 are rarely mutated in cancers. Instead, up-regulation of the anti-apoptotic dominant-negative ΔNp73 and ΔNp63 isoforms is the most frequent abnormality in solid cancers. In hematological malignancies the most frequent p73 defect is promoter methylation and loss of expression, associated with unfavorable clinical outcomes. This suggests an essential tumor suppressor role of p73 in blood cells, also supported by genetic mouse models. Many therapeutic approaches aiming to restore p73 activity are currently being investigated. In contrast, the most frequent p63 abnormality is protein overexpression, associated with higher disease grade and poorer prognosis. Surprisingly, although available data are still scarce, the emerging picture is up-regulation of transactivation-competent TAp63 isoforms, suggesting a tumor-promoting role in this context.Keywords
This publication has 106 references indexed in Scilit:
- p63–microRNA feedback in keratinocyte senescenceProceedings of the National Academy of Sciences, 2012
- Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targetsProceedings of the National Academy of Sciences, 2011
- An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcriptionNucleic Acids Research, 2011
- p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53Cell Death & Differentiation, 2011
- Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cellsCell Death & Differentiation, 2011
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAsNature, 2010
- MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1Immunity, 2010
- TAp63 induces senescence and suppresses tumorigenesis in vivoNature Cell Biology, 2009
- p63heterozygous mutant mice are not prone to spontaneous or chemically induced tumorsProceedings of the National Academy of Sciences, 2006